Back to ICCC

MORGAN STANLEY → ICCC

MORGAN STANLEY ICCC Position History

ImmuCell Corporation • Healthcare

Quarters held
12
Latest value
$2.2M
Q3 2026
Peak value
$2.4M
First seen
Q2 2024

Dollar value over time

Show data table
PeriodPosition value
Q2 2024$324K
Q3 2024$231K
Q4 2024$325K
Q1 2025$368K
Q2 2025$730K
Q3 2025$657K
Q3 2025$657K
Q4 2025$767K
Q4 2025$767K
Q1 2026$1.4M
Q2 2026$2.4M
Q3 2026$2.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2.2M221.1K——
Q2 2026$2.4M233.9K——
Q1 2026$1.4M221.7K——
Q4 2025$767K124.7K——
Q4 2025$767K124.7K——
Q3 2025$657K105.1K——
Q3 2025$657K105.1K——
Q2 2025$730K104.9K——
Q1 2025$368K76.9K——
Q4 2024$325K63.1K——
Q3 2024$231K63.5K——
Q2 2024$324K66.8K——

Other funds holding ICCC

Other MORGAN STANLEY positions

AAPL

APPLE INC

$32.3B
AAPL

APPLE INC

$28.6B
AAPL

APPLE INC

$27.2B
AAPL

APPLE INC

$27.2B
NVDA

NVIDIA CORPORATION

$26.9B
AAPL

APPLE INC

$25.7B
AAPL

APPLE INC

$25.4B
AAPL

APPLE INC

$25.4B